Aveanna Reports Q3 2026 Revenue Growth of 11.8% and Adjusted EBITDA Growth of 25%
Aveanna reported Q3 2026 revenue of $695.5M, up 11.8%, and Adjusted EBITDA of $100.1M, up 25% YoY. Gross margin increased 11.8% to $226.8M. Revenue grew across all segments. YTD free cash flow improved by $55M. Liquidity was $492.1M as of October 3, 2026, including $197.8M in cash.
How this was made

The 30-second read
Why it matters
The earnings beat signals operational strength and may prompt analysts to raise forecasts, supporting a short‑term rally.
Market read
First‑time earnings disclosure with solid growth; relevant for healthcare‑sector traders.
What to watch
Potential headwinds from reimbursement policy changes or staffing shortages in home‑health services.
Background
Aveanna Healthcare Holdings Inc (AVAH) is a provider of home health, hospice, private duty, and medical solutions services.
Ticker impact
Aveanna Healthcare reported Q3 2026 revenue of $695.5M (+11.8%) and adjusted EBITDA of $100.1M (+25%) – first public disclosure of these earnings figures.
likely upward pressure as the market prices in better‑than‑expected growth
Revenue and EBITDA both rose double‑digit year‑over‑year, exceeding typical expectations for a mid‑cap healthcare services firm.
Market effects
May boost sentiment for the home‑health and hospice sector as a peer shows strong growth.
Limited to U.S. healthcare services investors.
Low; impact confined to sector‑specific investors.
Counterpoint
If guidance falls short of market expectations despite growth, the stock could face disappointment.
Key entities
- companyAveanna Healthcare Holdings Inc
U.S. listed provider of home‑health and related services.
